key: cord-0888443-dtc6lspb
authors: Forman, Marnin A.; Steiner, Joerg M.; Armstrong, P. Jane; Camus, Melinda S.; Gaschen, Lorrie; Hill, Steve L.; Mansfield, Caroline S.; Steiger, Katja
title: ACVIM consensus statement on pancreatitis in cats
date: 2021-02-15
journal: J Vet Intern Med
DOI: 10.1111/jvim.16053
sha: cdbd30a251ae15a6b5de8e3182927c53958e9de1
doc_id: 888443
cord_uid: dtc6lspb

BACKGROUND: Pancreatitis in cats, although commonly diagnosed, still presents many diagnostic and management challenges. OBJECTIVE: To summarize the current literature as it relates to etiology, pathogenesis, diagnosis, and management of pancreatitis in cats and to arrive at clinically relevant suggestions for veterinary clinicians that are based on evidence, and where such evidence is lacking, based on consensus of experts in the field. ANIMALS: None. METHODS: A panel of 8 experts in the field (5 internists, 1 radiologist, 1 clinical pathologist, and 1 anatomic pathologist), with support from a librarian, was formed to assess and summarize evidence in the peer reviewed literature and complement it with consensus clinical recommendations. RESULTS: There was little literature on the etiology and pathogenesis of spontaneous pancreatitis in cats, but there was much in the literature about the disease in humans, along with some experimental evidence in cats and nonfeline species. Most evidence was in the area of diagnosis of pancreatitis in cats, which was summarized carefully. In contrast, there was little evidence on the management of pancreatitis in cats. CONCLUSIONS AND CLINICAL IMPORTANCE: Pancreatitis is amenable to antemortem diagnosis by integrating all clinical and diagnostic information available, and recognizing that acute pancreatitis is far easier to diagnose than chronic pancreatitis. Although both forms of pancreatitis can be managed successfully in many cats, management measures are far less clearly defined for chronic pancreatitis.

both forms of pancreatitis can be managed successfully in many cats, management measures are far less clearly defined for chronic pancreatitis.

cat, diagnosis, etiology, gastroenterology, management, pancreas, pancreatitis, pathophysiology 1 | INTRODUCTION Pancreatitis historically has been considered rare in cats, but current evidence suggests that this disease is quite common, similar to the situation in both humans and dogs. 1 In a study of 115 cats undergoing necropsy at the University of California Davis, the overall histopathologic prevalence of pancreatitis was 66.1%, with 50 .4% of cats having evidence of chronic pancreatitis alone, 6.1% having evidence of acute pancreatitis alone, and 9.6% having evidence of both acute and chronic pancreatitis. Also, 45% of the apparently healthy cats had evidence of pancreatitis. 1 This finding raises the question as to whether there is a population of cats with subclinical pancreatitis or whether the current histopathologic definition of pancreatitis leads to overdiagnosis and needs clarification.

In contrast to these histopathological data, clinical pancreatitis is diagnosed much less frequently in cats, but the consensus panel agrees that the frequency of a diagnosis of pancreatitis has increased steadily over the last 2 decades, mainly because of an increased level of awareness and availability of noninvasive and minimally invasive diagnostic tests. Management of pancreatitis in cats remains challenging and definitive treatments are currently unavailable.

Although in humans the definition and classification of pancreatitis have been standardized by integrating different medical disciplines, the classification of pancreatitis in cats lacks standardization. 2, 3 In general, acute pancreatitis is characterized by inflammation that is completely reversible after removal of the inciting cause, whereas chronic pancreatitis results in irreversible histopathologic changes. 1, 4 The differences between acute and chronic pancreatitis are mainly histopathologic, and not necessarily clinical. 5 Thus, it may be impossible clinically to distinguish an exacerbation of chronic pancreatitis from an episode of acute pancreatitis. 4, 6 Both acute and chronic pancreatitis can be mild or severe, but chronic cases are more commonly mild and acute cases more commonly severe. Clinically, mild pancreatitis is associated with few systemic complications, minimal pancreatic necrosis, and generally a low mortality, although morbidity may be impacted by concurrent diseases. In contrast, clinically severe pancreatitis is characterized by extensive pancreatic necrosis, multiple organ involvement or even failure, and in some cases a poor prognosis. 7 Pancreatitis can be accompanied by uncommon pancreatic complications, the terminology of which historically has been confusing in cats. In humans, the current consensus statement defines acute peripancreatic fluid accumulations, acute necrotic collections or, late after the onset of acute pancreatitis, pseudocysts or walled-off necrosis; each may be sterile or infected with bacteria. 2 These fluid accumulations have been described previously as phlegmons or abscesses in cats. 2, 7 3 | ETIOLOGY Pancreatitis has no age, sex, or breed predisposition. 1 Additionally, associations with body condition score, dietary indiscretion, or drug history have not yet been established in cats.

Although pancreatitis has been observed in cats with various infections, including certain parasites (eg, Toxoplasma gondii, Eurytrema procyonis, Amphimerus pseudofelineus) and viruses (eg, coronavirus, parvovirus, herpesvirus, calicivirus), these infections represent rare causes of pancreatitis in cats. 6, [8] [9] [10] Intraoperative manipulation of the pancreas and pancreatic biopsy have been suggested as risk factors for the development of pancreatitis, but hypotension associated with anesthesia may be more important than pancreatic manipulation. 1 Although pancreatic injury is possible with manipulation, an increased risk for the development of pancreatitis has not been noted in studies involving pancreatic sampling. 11, 12 Neoplasia involving the pancreas has been associated with pancreatitis, but is not diagnosed commonly in cats. 13 Pancreatic trauma after road accidents or falling from high buildings, potentially resulting in pancreatic ischemia, has been established as a cause. 14 Two cases of pancreatitis in cats after topical use of fenthion, an organophosphate cholinesterase inhibitor, have been reported. 15 Many other pharmaceutical compounds, such as potassium bromide or phenobarbital, have been implicated in causing pancreatitis in humans and dogs, but have not been reported to cause pancreatitis in cats. 16, 17 Hypercalcemia and snake bites have been reported to rarely cause acute pancreatitis in other species and in experimental models in cats. [18] [19] [20] Autoimmune pancreatitis (AIP) occurs uncommonly in people. It can be categorized as type 1 when the pancreas is involved in a multisystemic fibro-inflammatory disease (also known as immunoglobulin 4 -associated systemic disease) and as type 2, which has been associated with chronic enteropathy. 21 The presence of IgG4-staining cells in the pancreas and incidence of circulating antibodies against the pancreas have not been established in cats, but response to immunosuppressive therapy with chronic pancreatitis may suggest an immune-mediated etiology in some cats.

Pancreatitis in cats has been associated with several concurrent diseases, including diabetes mellitus, chronic enteropathies, hepatic lipidosis, cholangitis, nephritis, and immune-mediated hemolytic anemia. [22] [23] [24] [25] [26] Whether these conditions cause, or are risk factors for, pancreatitis has not been determined. 23, 24, 27 In summary, > 95% of cases of pancreatitis in cats are considered to be idiopathic, and a specific cause cannot be identified.

Premature activation of pancreatic digestive enzymes within acinar cells, leading to activation of other zymogens and resulting in pancreatic autodigestion, is assumed to play an important role in the pathogenesis of pancreatitis in both humans and cats ( Figures 1-3) . The pancreas has several safeguards in place to protect against activation of zymogens of digestive enzymes (ie, inactive preforms of digestive enzymes) within acinar cells ( Figure 1A ). [28] [29] [30] [31] Hypotheses for the spontaneous development of pancreatitis ( Figure 1B ) include autoactivation of cationic trypsinogen (more likely when pH ≥5.0) 29, 30 ; activation of zymogens by thrombin during bacterial toxemia, ischemia, or hypoxia 29 ; colocalization of lysosomal proteases and zymogen granules (because of an apical block of zymogen granule secretion) 29 ; activation of trypsinogen by cathepsin B 29-32 ; and, enterokinase entering the portal circulation after a meal in conjunction with biliary-pancreatic reflux, which may cause zymogen activation. 29 F I G U R E 1 Mechanisms that protect the pancreas from premature activation of zymogens (panel A). Events that can lead to acute pancreatitis due to premature activation of trypsinogen (panel B) F I G U R E 2 Local and systemic inflammation ensues in acute pancreatitis, which is independent of trypsin activation, but dependent on ongoing stimulation of the NFκB pathway F I G U R E 3 The pathophysiological mechanisms relevant for chronic pancreatitis that occur independently of trypsin activation and acute pancreatitis Over the past 3 decades, studies have concluded that trypsinogen activation within the pancreas is the initiating event for acute pancreatitis. 33, 34 However, there is no consensus on how this inciting event unfolds. Recent hypotheses postulate that abnormalities in calcium signaling lead to the colocalization of lysosomes and zymogen granules and trypsinogen activation, causing acinar cell death and early activation of the nuclear factor kappa B (NFκB) pathway. [35] [36] [37] However, the local and systemic inflammation that ensues in acute pancreatitis is independent of trypsin activation, but dependent on ongoing stimulation of the NFκB pathway. 38, 39 The events that follow include an influx of neutrophils, increased vascular permeability, and loss of apical paracellular barriers. All of these events worsen acinar cell, organ, vascular, and systemic injury. 40 The extent of systemic inflammation in an individual cat depends on the degree of compensatory anti-inflammatory responses that are present. 41 This proposed cascade of systemic inflammatory and compensatory antiinflammatory pathways during acute pancreatitis has been described extensively in experimental rodent models and people, but it is unknown whether this cascade also occurs in cats. [42] [43] [44] [45] [46] [47] [48] Hypoperfusion and thrombosis also may serve as triggers for the development of peripancreatic necrosis. 40 Additionally, high concentrations of bile acids or trypsin within the pancreatic circulation may contribute to the development of necrosis, although this has been identified only in a feline pancreatitis model. 49 Overall, most experimental models of pancreatitis fail to replicate the events that occur in vivo in cats. However, it has been shown that cats do have increased pancreatic permeability in response to infusion of some substances, such as ethanol, but not sterile bile. 50, 51 Experimentally, infusion of infected bile into the pancreatic duct induced severe pancreatitis, but when bacteria suspended in saline were infused, only mild pancreatitis developed. 50, 51 The unique anatomy of the cat, with shared entry of the common bile duct and the pancreatic duct into the duodenum, may explain the association between acute cholangitis or bacterial cholecystitis and pancreatitis.

When chronic pancreatitis occurs independently of acute pancreatitis, trypsin activation is not considered the inciting event. 52 Studies suggest that cholecystokinin and oxidative stress synergistically sensitize pancreatic acinar cells to injury and necrosis, independent of trypsin activation. 53 This occurs via calcium ion signaling and collapse of the mitochondrial membrane potential.

In people, an acute initial insult, which may lead to subclinical disease, exposes the pancreas to oxidative stress that causes activation of pancreatic stellate cells (PSC). 54 These PSCs are the source of fibrosis and, if exposed to continued stimulation by low-grade inflammation (ie, platelet-derived growth factor, transforming growth factor β, tumor necrosis factor α, and interleukins [IL]-1, IL-6, and IL-10), or recurrent oxidative stress, periacinar fibrosis develops. 55 Also, lipopolysaccharides can activate PSCs by activation of toll-like receptor-4, suggesting a potential role of endotoxemia in the pathogenesis of pancreatic fibrosis. 56 Additionally, metabolites accumulate within the pancreas because of decreased blood flow and potentially acidosis and low-grade ongoing activation of trypsinogen to trypsin. 57 Ductal obstruction may develop as part of this process, further exacerbating the low-grade inflammation and fibrosis. This may occur because of precipitation of protein and calcium in the duct after a decrease in bicarbonate secretion, as well as decreased fluid volume of pancreatic secretions. 56 In feline experimental models, chronic pancreatitis may result from simple obstruction of the pancreatic duct, but this is unlikely to be the primary pathogenesis in naturally occurring disease. 50, 51 Damage to the ductal epithelium independent of ductal obstruction has been shown experimentally to be essential for development of chronic pancreatic inflammation in cats. 58 Primary inflammation in neighboring abdominal organs, such as the biliary system or the intestines, also may cause inflammatory changes within the pancreas by upregulation of inflammatory mediators, their receptors, or both. 56 

Clinical signs and physical examination findings associated with both acute and chronic pancreatitis in cats are nonspecific (see Table 1 ).

The presenting signs in each case help to categorize the severity of the disease. Interestingly, in contrast to people, where abdominal pain is considered a hallmark finding of the disease, cats with pancreatitis infrequently are reported to have abdominal discomfort. However, the panel feels that this discrepancy is most likely because of underrecognition of abdominal pain in cats. Additional clinical signs may be caused by concurrent diseases. 59 6 | DIAGNOSTIC IMAGING

Abdominal radiography is neither sensitive nor specific for the diagnosis of pancreatitis in cats. 64 The left lobe of the pancreas occasionally T A B L E 1 Incidence of clinical signs and physical examination findings reported in cats with pancreatitis 11, 15, [59] [60] [61] [62] [63] Clinical sign Incidence % can be identified on ventrodorsal radiographs in cats with pancreatitis.

Radiographic signs of severe pancreatitis in cats can include loss of peritoneal detail in the cranial abdomen or a mass effect. Although both can be assessed by radiography, neither finding is specific for pancreatitis. 65 Endoscopic retrograde cholangiopancreatography has been reported in healthy cats as a contrast fluoroscopic technique to assess the biliary tract and the exocrine pancreas, but is technically challenging, requiring special equipment and expertise, and is not yet established as a diagnostic test in cats. 66 

Ultrasonography remains the most routine diagnostic imaging modality for cats suspected of having pancreatitis and should be considered part of the minimum database in these cats. Furthermore, cats with gastrointestinal signs may have comorbidities of the intestines, liver, and gallbladder, which also can be assessed using this modality. 67 Although high frequency transducers (>7.5 MHz), either curved or linear array, allow good visualization of the feline pancreas, pancreatic duct, surrounding mesentery, and vasculature, some limitations remain. These include ultrasonographer experience and lack of specificity to differentiate normal pancreas from acute or chronic pancreatitis and to differentiate hyperplasia from neoplasia when nodules or masses are detected. 68 After clipping the ventral abdomen, swabbing with alcohol, and applying ultrasound gel, the examination begins by identifying the portal vein at the porta hepatis, where the blood vessels and the common bile duct exit the liver. The portal vein then is traced caudally to the caudal border of the stomach where the pancreatic body can be seen ventral to the portal vein. 69 The normal pancreas is isoechoic or hypoechoic compared to the surrounding mesentery and is similar in echogenicity to the liver. The left lobe of the pancreas is located between the caudal curvature of the stomach and the cranial border of the transverse colon and is more readily visible than the right lobe. 70 The pancreatic duct usually is identified as a small hypoechoic tubular structure centrally located within the left lobe of the pancreas.

The right pancreatic lobe is small and can be difficult to identify. It is best located by tracing the pancreatic body to the right of the portal vein and searching medial to the duodenum.

The thickness of the left lobe ranges from 5-9 mm, whereas the right lobe is 3-6 mm. 70 In cats <10 years of age, the mean duct diameter has been reported as 0.8 ± 0.25 mm and in cats >10 years of age as 1.2 ± 0.4 mm (ranging from 0.5 to 2.5 mm) in diameter. 70, 71 Sonographic findings in acute pancreatitis in cats ( Figure 4 ) may be equivocal or may include pancreatic enlargement, a hyperechoic surrounding mesentery, and focal abdominal effusion. 65 The duodenum can be distended or corrugated. The sensitivity of these findings for diagnosing acute pancreatitis in cats has been reported to range between 11% and 67%, and sensitivity is considered to be severitydependent and operator-dependent. 65 Pancreatic ultrasonography has developed over the last 3 decades and thus results of the various papers reporting on sensitivity may not be directly comparable.

Ultrasonographic features of chronic pancreatitis ( Figure 5 ) are not well established in cats. 59, 72 Findings may include a hyperechoic or mixed echoic pancreas, a dilated common bile duct, enlarged pancreas, and irregular pancreatic margins. 72 Because of overlap between these features and those of acute pancreatitis, ultrasonography is a poor diagnostic tool for assessing chronicity. 59 Pancreatic nodular hyperplasia can be an incidental finding in older cats. 68 Abdominal ultrasound examination also can be used to collect cytological samples. Ultrasound-guided fine-needle aspiration of the feline pancreas frequently is performed using a 20G or 22G hypodermic or spinal needle and is safe in cats, including those with pancreatitis. 73 An optimal technique has not been determined. One study found a 67% cell recovery rate of diagnostic samples (24/73 samples were nondiagnostic). 73 To optimize sample distribution for microscopic evaluation, samples obtained by fine-needle aspiration should be smeared gently and quickly, as would be done with peripheral blood. 74 Pancreatic acinar cells deteriorate quickly, because of release of digestive enzymes, making rapid cell preservation imperative. 75 

Contrast-enhanced Doppler ultrasonography of the pancreas has not gained wide use in cats for the diagnosis of pancreatitis. 76, 77 Recent studies have established the multiphase contrast enhanced computed tomography (CT) features of the normal and abnormal feline pancreas. [78] [79] [80] [81] The pancreas in healthy cats enhances homogenously on arterial, portal, and delayed phase scans. The pancreas is hypoattenuating or isoattenuating to the liver and spleen on precontrast scans. 82 Azotemia has been linked to progression of the disease. 63 Hypoglycemia and hyperglycemia can be seen with acute necrotizing and suppurative pancreatitis, and hypoglycemia has been associated with poor outcome. 15, 63 In other species, pancreatitis is associated with hyperlipidemia, consisting of increased serum triglyceride or cholesterol concentrations, or both. [88] [89] [90] In cats however, hypertriglyceridemia is rare and no association of hypertriglyceridemia with pancreatitis has been reported. 86, 88, 91 Changes in serum electrolyte concentrations are variable, particularly depending on the hydration status of the patient, but hypokalemia, hypochloremia, hyponatremia, and hypocalcemia are the most common electrolyte abnormalities in cats with severe acute pancreatitis. 86 

Pancreatic acinar cells synthesize and secrete a wide variety of digestive enzymes (eg, amylase, lipase, DNAse, and RNAse) and inactive preforms of digestive enzymes (zymogens; eg, trypsinogen, chymotrypsinogen, proelastase, prophospholipase), which are all released into the small intestine via the pancreatic duct. 92 However, small amounts of these enzymes and zymogens reach the vascular space. In principle, when the pancreas undergoes inflammation or damage, zymogen granules leak from the acinar cells into the interstitial space, ultimately reaching the vascular space.

Measurement of any pancreatic enzyme or zymogen theoretically could be used as a diagnostic marker for acinar cell damage and pancreatitis. However, some enzymes are very small or are scavenged by inhibitors or both, and are rapidly cleared from the bloodstream. The source of other enzymes is not limited to pancreatic acinar cells. Thus, an ideal marker for pancreatitis would be one that is synthesized only by acinar cells and not cleared immediately from the vascular space.

Pancreatic lipase fulfills these criteria, but to be useful as a biomarker, the molecule must be measured using an assay specific for pancreatic lipase, which can be problematic. 100 The authors suggested that a positive Spec fPL result indicated pancreatitis as a probable diagnosis, but that the test cannot be used to rule out pancreatitis. 100 However, cases in this study were not further categorized based on severity or acute vs. chronic disease. 100 One study reported lower diagnostic accuracy in cats with pancreatitis than did other studies, the reason for this discrepancy is unclear. 72 

Historically, increases in serum amylase activity have been associated with acute pancreatitis in some cats. However, because of both, poor diagnostic sensitivity and lack of tissue specificity, enzymatic activity of amylase has minimal utility as a biomarker for pancreatitis in cats. 86, 94, 105 Trypsin-like immunoreactivity (TLI) measures trypsinogen, trypsin, and likely some trypsin that has been bound by protease inhibitors and is measured using a species-specific immunoassay. Studies indicate variable results in cats with pancreatitis, with sensitivity ranging from 30-86%. 105, 106 Because trypsinogen is produced by pancreatic acinar cells, some cats with chronic pancreatitis and subsequent pancreatic atrophy ultimately have a decreased serum fTLI, indicating exocrine pancreatic insufficiency. Also, increased serum fTLI concentrations previously have been associated with acute pancreatitis in cats. 106 However, this test is nonspecific and increased serum fTLI concentrations also have been associated with chronic enteropathy and gastrointestinal lymphoma, and may occur in cats with a decreased glomerular filtration rate 86, 105 Thus, the utility of fTLI for the diagnosis of pancreatitis in cats is limited.

Trypsinogen activation peptide (TAP) is a byproduct of trypsinogen activation that normally is excreted in the urine. In health, this Nterminal peptide is present in very low concentrations in both urine and serum. 105 In cats with acute pancreatitis, TAP is formed at a higher rate because of rapid cleavage of trypsinogen by cathepsin B or through autoactivation. 107 Although initially considered to be a promising biomarker for the detection of pancreatitis, inconsistent performance characteristics and lack of commercial availability limit the utility of this analyte. 107 

Cytology allows for close examination of a focal area of aspiration, but individual aspirates may not be representative of the tissue as a whole. With acute pancreatitis, pancreatic aspirates often are highly cellular. They are characterized by inflammatory cells, predominantly neutrophils, that show variable degrees of degeneration with fewer foamy macrophages on a background of amorphous, necrotic debris, which occasionally contains refractile crystalline material ( Figure 6 ). 74, 108 The inflammatory cells often are closely associated with pancreatic acinar cells, with fewer ductal epithelial cells. 74 In the presence of inflammation, acinar cells may appear dysplastic, with evidence for cytomegaly, karyomegaly, prominent nucleoli, and increased cytoplasmic basophilia. 74 It is extremely difficult to distinguish cytologically between primary pancreatitis with dysplastic epithelial cells and an inflamed pancreatic carcinoma. 74, [108] [109] [110] However, pancreatic neoplasia is rare in cats and is considered much less likely. 13 With chronic pancreatitis, pancreatic aspirates often are poorly cellular, because of the presence of fibrosis, which occasionally forms 1 or more mass-like lesions. 110 There is a cluster of acinar cells (arrow) surrounded by erythrocytes and many nondegenerate neutrophils (arrowheads), consistent with suppurative pancreatic inflammation necrosis, focal peritonitis, or pancreatic hemorrhage, edema, and congestion or, in cases with severe pancreatic necrosis, fibrin strands that pass from the pancreatic surface to the omentum, mesentery, or visceral surfaces of the liver. 117 Gross lesions of chronic pancreatitis often are more subtle, but in severe cases, the pancreas may be small with a firm, gray, multinodular appearance, 117 or with a dull granular capsular surface. 118 Adhesions to the small intestine also may be present. 116 

Although the relevance of histologic classification of pancreatitis in cats, especially with respect to clinical findings and prognosis, remains unclear, 5 some histologic standards for the classification of pancreatic inflammatory disease in cats are provided.

In general, interpretation of pancreatic biopsy specimens should include evaluation of inflammatory cell infiltrates as well as their spatial distribution (ie, intralobular vs. interlobular) and the presence of edema, necrosis, fibrosis, amyloid, cystic acinar degeneration, or acinar atrophy. 1 The consensus panel agreed that these histologic findings should be reported following a previously published scoring system, which has been slightly modified by the consensus panel (Table 2 ). 1 

showing fat necrosis (star) and focal suppurative infiltration (arrow) with early focal acinar-to-ductal metaplasia (arrowhead). Scale bar = 100 μm

In general, pancreatic biopsy in cats with suspected moderate or severe acute pancreatitis is infrequently performed (Figure 7) . Thus, the majority of knowledge of histologic changes in cats with acute pancreatitis is from necropsy material. 1, 15, 49, 119 One study divided acute pancreatitis in cats into 2 forms: acute necrotizing pancreatitis with substantial necrosis and acute suppurative pancreatitis where necrosis is not a feature. 15 This approach corresponds to the classification of acute pancreatitis in humans with a mild interstitial form with little or no necrosis and a severe necrotizing form. 120 Additional studies are needed to determine if these 2 morphologies are truly distinct in cats.

Chronic pancreatitis in cats is characterized histologically by lymphocytic or lymphoplasmacytic inflammation, fibrosis, and acinar atrophy ( Figure 8 ). 1, 117 Retention cysts (ie, microscopic intraparenchymal cysts) may be visible and, although the most frequent type of pancreatitis in cats is mild, 1,116 fibrosis can be extensive throughout the interlobular septa and extend into the lobules in severe cases. 117 Extensive periductal fibrosis also may be present, leading to localized stenosis and cyst formation, with squamous metaplasia of the ductal epithelium. 117 Acinar-to-ductal metaplasia also can be present. Pancreatic neoplasia also can be associated with chronic pancreatitis. 13 Morphologically, chronic pancreatitis in cats resembles the most frequent type of chronic pancreatitis in humans, which is alcohol-induced chronic pancreatitis. 121 

Intravenous crystalloid fluid is administered to correct dehydration and electrolyte imbalances. In addition to the adverse effects of hypovolemia, the pancreas also is susceptible to altered blood flow as a result of increased vascular permeability (because of inflammation and acinar cell injury) and microthrombi formation (because of hypercoagulability). 131 Establishing normovolemia using early IV fluid therapy may limit tissue damage by improving pancreatic perfusion and oxygen delivery. In humans, early aggressive hydration with lactated Ringer's solution hastens clinical improvement in patients with acute pancreatitis. 124, 125 The duration of clinical signs before presentation to the hospital is directly proportional to the odds of death, which is attributed, at least in part, to hypovolemia. 63 In cats with functional gastroparesis or ileus, prokinetic treatment can be effective at improving motility. Metoclopramide has questionable central antiemetic effects in cats, but when administered as a constant rate infusion (CRI), metoclopramide increases gastric emptying and decreases gastric atony. [136] [137] [138] [139] One study suggested a contraindication to the use of metoclopramide because of dopamine antagonism in cats with pancreatitis, but no clinical studies have confirmed such a contraindication. 127 Compounded cisapride is an effective PO prokinetic in cats and is the treatment of choice for delayed gastric emptying. 140, 141 Erythromycin also has been shown to have a gastric prokinetic effect in cats. 136 

Pain is difficult to evaluate in cats. 142 lethargy) with more adverse effects noted at higher dosages. 151 An additional benefit of mirtazapine may be its antiemetic activity. 152 Mirtazapine transdermal ointment can be used in cats and generally is well-tolerated and efficacious. 153 The safety and efficacy of capromorelin PO solution as an appetite stimulant have been reported in healthy cats. 154 Also, capromorelin recently has been approved for use in cats with chronic kidney disease (CKD) in the United States and can be considered as an appetite stimulant for cats with pancreatitis.

Nutritional support plays a central role in the management of acute pancreatitis in humans. Lack of enteral nutrition may lead to impaired gastrointestinal motility, intestinal villous atrophy, compromised intestinal blood flow, altered barrier function, and disruption of the normal intestinal microbiota. 155, 156 Thus, in patients with severe acute pancreatitis, early enteral nutrition is viewed as an active therapeutic intervention that minimizes infected pancreatic necrosis and decreases the incidence of multiple organ failure, thus improving outcome. 157, 158 In contrast, prolonged fasting or parenteral nutrition is no longer recommended unless enteral nutrition cannot be achieved.

Early enteral nutrition was evaluated in a prospective randomized trial of humans with severe acute pancreatitis, and compared nasojejunal and nasogastric routes of feeding. It was determined that enteral nutrition was tolerated by both routes with no difference in outcome measures. 159 The International Consensus Guidelines Committee supports the use of nasogastric tube feeding in humans with acute pancreatitis within 24 hours after hospital admission. 160 In patients with severe acute pancreatitis, enteral nutrition may be provided by the gastric or jejunal route if PO feeding is not tolerated. 157, 161 Limited information about the optimal nutritional management of acute pancreatitis is available for cats. 162 Evidence in studies of humans with pancreatitis and the results of experimental and clinical studies in animals support the use of enteral nutrition. 155,157,158,160-170 Because most cats with pancreatitis have been inappetent for a variable period of time, any withholding of food may be detrimental and is not recommended. Additionally, some cats, when inappetent or prevented from eating, will develop hepatic lipidosis, which will substantially increase mortality. 22 In cats with acute pancreatitis, PO feeding or enteral nutrition via tube feeding should be initiated early. Cats with mild to moderate acute pancreatitis often begin to eat with appropriate supportive and symptomatic care, whereas severe cases with complications often will require a feeding tube for appropriate alimentation. Additionally, a feeding tube can be used for hydration, administration of PO medications, and for gastric decompression, when indicated. The dietary needs for cats with acute pancreatitis have not been determined. Cats have high dietary protein requirements, making them susceptible to protein-energy malnutrition and lean muscle mass loss during starvation. 171, 172 Also, cats have a higher tolerance for dietary fat than do dogs. Additionally, decreased dietary arginine and methionine may limit the synthesis of hepatic lipoproteins and phospholipids, which may contribute to the development of hepatic lipidosis. 173 Highly digestible diets, often labeled as "gastrointestinal diets," are recommended. Severely ill cats are prone to food aversion and it may be prudent to delay the use of the long-term diet of choice until the cat has improved and is being fed at home.

Placement of an enteral feeding tube is indicated for cats that fail to respond to appetite stimulants within 48 hours or those that have a history of more prolonged anorexia before presentation.

Nasoesophageal tubes ( Figure 9A ) or esophagostomy tubes ( Figure 9B ) are the most commonly placed tubes in cats with acute pancreatitis. Nasogastric tubes also are appropriate for short-term use in hospitalized cats and allow for gastric suctioning when indicated. 162 However, nasogastric suctioning in humans with pancreatitis has been reported to lead to worsening gastric distension, gastro-esophageal reflux, pain, and nausea and the efficacy of gastric suctioning has not yet been evaluated in cats with pancreatitis. 173, 174 Gastrostomy tubes or jejunostomy tubes placed endoscopically or surgically are less commonly utilized. Nasoesophageal tubes are cost-effective and easily placed under local anesthesia, avoiding the need for general anesthesia, and are a good choice for short-term nutritional support of hospitalized or severely debilitated cats. With nasoesophageal tubes, feeding is limited to a liquid diet. Placement of esophagostomy tubes requires general anesthesia and more technical expertise, but is an excellent option when long-term feeding is anticipated.

Esophagostomy tubes allow for feeding of canned diets as a gruel.

For cats in which enteral feeding is not an option because of unmanageable vomiting, short-term alimentation can be provided by partial or total parenteral nutrition. However, survival rates for cats receiving partial parenteral nutrition exclusively are lower than in cats receiving supplemental enteral nutrition. 175 

In addition to supportive and symptomatic care, cats with severe nec- 

In humans, antibiotics are not recommended in management of acute pancreatitis unless an infection is strongly suspected or has been confirmed. 180 In veterinary medicine, acute pancreatitis is considered to be a sterile process, based, in most instances, on inability to detect microbial growth using routine bacterial culture media. Antibiotics are not recommended for noncomplicated cases of pancreatitis. Reports of bacterial complications, such as pancreatic abscessation, are rare. 11 Broad-spectrum antibiotics should be reserved for cats with acute pancreatitis in which pancreatic infection is suspected or confirmed (eg, pancreatic abscess, infected necrotic tissue), infection has ascended the common pancreatic or bile duct, or CBC findings are suggestive of sepsis. 11, 122, 181 Bacterial infections can occur with concurrent disorders, including cholangitis and aspiration pneumonia.

Fluorescence in situ hybridization has identified bacteria in the pancreas of 35% of cats with moderate to severe pancreatitis. 182 The localization and type of intrapancreatic bacteria suggest translocation of enteric bacteria as a likely source. 182 [192] [193] [194] [195] Also, HBOT has not been included in current treatment guidelines for humans with pancreatitis. 196 Until clinical studies are performed in cats, routine use of this modality in cats cannot be recommended.

The mortality rate in cats with acute pancreatitis ranges from 9% to 41%, based on 4 studies. 60 60, 197 Hypoglycemia and azotemia also are poor prognostic indicators. 63 Mortality in humans with acute pancreatitis is reported to be 5%-15%, but it has decreased over time and overall mortality of people with acute pancreatitis is approximately 2% with state-of-the-art standard of care. 161 

Visceral pain is mediated by cytokines, substance P, neurokinin A, and calcitonin gene peptide, and thus traditional analgesics may not be effective in cats with chronic pancreatitis. 199 During overt bouts of disease, transmucosal buprenorphine can be administered. For longterm treatment, gabapentin or tramadol may be better choices. 200 Maropitant, often selected for control of vomiting, also may provide visceral analgesia in cats. 201 Supplementation of pancreatic enzymes has been suggested in humans with pancreatitis to potentially decrease pain associated with feeding, but doing so is no longer recommended unless subclinical exocrine pancreatic insufficiency is present. 202 Development of feline-specific monoclonal antibodies targeting pain mediators is a promising area of research that may transform pain management in cats with pancreatitis. 203 

Enteral nutritional support or dietary modification may be required for treatment of underlying or concurrent diseases, but rarely is required to manage chronic pancreatitis as a primary condition. 

During bouts of vomiting or when inappetence is attributable to nausea, antiemetic treatment using maropitant or a 5HT 3 antagonist should be considered. Appetite stimulants, such as mirtazapine, may be useful to help maintain voluntary food intake.

Bacterial infection is not implicated in chronic pancreatitis and antimicrobials are not indicated unless required to treat concurrent conditions or infectious complications.

Cobalamin supplementation is indicated when hypocobalaminemia is documented. It may be considered when anorexia or concurrent gastrointestinal disease is present.

Inflammation and subsequent fibrosis are important pathologic aspects of chronic pancreatitis in cats and may lead to subsequent deficiencies of the exocrine or endocrine functions of the pancreas.

Prednisolone is a commonly used anti-inflammatory and immunosuppressive drug that is potentially antifibrotic and has minimal adverse effects in cats when used at low doses. The adverse effect of most concern is enhanced peripheral insulin resistance, and the risk of diabetes mellitus.

Although some panel members felt that prednisolone should only be used in cats that are not hyperglycemic and only at antiinflammatory dosages (ie, 0.5-1.0 mg/kg PO q24h on a tapering schedule), other panel members felt that immunosuppressive dosages of prednisolone (eg, 2.0 mg/kg q12h for 5 days and then 1.0 mg/kg q12h for 6 weeks with a decreasing dosing schedule after that time)

with close monitoring (ie, clinical re-evaluation and measurement of fPLI after 2-3 weeks) could have a beneficial effect. If hyperglycemia develops, or is pre-existing, some panel members recommend the use of cyclosporine (5 mg/kg q24h for 6 weeks) with close monitoring (ie, clinical re-evaluation and measurement fPLI after 2-3 weeks). 204, 205 In cats treated with either prednisolone or cyclosporine in which clinical signs have not improved and pancreatic lipase has not decreased, discontinuation of treatment should be considered. In cats that show a clinical response, continuation of treatment is indicated. Unmasking latent toxoplasmosis may be a concern with long-term use of high-dose cyclosporine. 206 Toxoplasmosis may be of a greater concern in geographic locations where cats frequently hunt in the wild or consume raw meat and has been reported in renal transplant cats and a cat treated for atopy. [207] [208] [209] Other immunosuppressive medications, such as chlorambucil, also may be beneficial, but have not been studied in cats with chronic pancreatitis.

If serum fPLI is increased at the time of diagnosis, it can be used to monitor response, along with clinical variables. However, the sensitivity of serum fPLI is lower in cats with mild disease than in those with severe disease and, like any other diagnostic test, this laboratory test should not be used in isolation to assess clinical remission.

In conclusion, although both acute and, especially, chronic pancreatitis are considered to occur commonly in cats, diagnosis remains challeng- 

Dr. J. Steiner serves as the director of the Gastrointestinal Laboratory at Texas A&M University, which offers measurement of fPLI concentration on a fee-for-service basis. Dr. Steiner also serves as a paid consultant and speaker for Idexx Laboratories, Westbrook, ME, the manufacturer of the Spec fPL and SNAP fPL assays and for ISK, Osaka, Japan, the manufacturer of fuzapladib. None of these organizations influenced the outcome of this consensus statement. None of the other authors declare any conflict of interest.

Authors declare no-off label use of antimicrobials.

Authors declare no IACUC or other approval was needed.

Authors declare human ethics approval was not needed for this study.

Joerg M. Steiner https://orcid.org/0000-0003-3336-2086

Prevalence and histopathologic characteristics of pancreatitis in cats

Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus

Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition

Chronic pancreatitis

Pancreatitis in dogs and cats: definitions and pathophysiology

Current concepts in feline pancreatitis

Hannover: Schlütersche-Verlagsgesellschaft mbH

Pancreatitis in cats

Serum feline pancreatic lipase immunoreactivity concentration and seroprevalences of antibodies against toxoplasma gondii and Bartonella species in client-owned cats

Eurytrema procyonis and pancreatitis in a cat

Feline acute pancreatitis: current concepts in diagnosis & therapy

Pancreatic surgical biopsy in 24 dogs and 19 cats: postoperative complications and clinical relevance of histological findings

Primary solid and cystic tumours of the exocrine pancreas in cats

Serum feline-specific pancreatic lipase immunoreactivity concentrations and abdominal ultrasonographic findings in cats with trauma resulting from high-rise syndrome

Acute necrotizing pancreatitis and acute suppurative pancreatitis in the cat

Drug-induced acute pancreatitis: an evidence-based review

Serum pancreatic lipase immunoreactivity concentrations in dogs treated with potassium bromide and/or phenobarbital

Hypercalcemic pancreatitis: from trypsinogen activation?

Hypercalcaemia and pancreatic ultrastructure in cats

Acute pancreatitis following adder bite in the UK: a case report

Autoimmune pancreatitis

Acute pancreatitis in cats with hepatic lipidosis

Relationship between inflammatory hepatic disease and inflammatory bowel disease, pancreatitis, and nephritis in cats

Association between pancreatitis and immunemediated haemolytic anaemia in cats: a cross-sectional study

Amyloidogenesis of feline amylin and plasma levels in cats with diabetes mellitus or pancreatitis

Feline comorbidities: what do we really know about feline triaditis?

Prevalence and clinicopathological features of triaditis in a prospective case series of symptomatic and asymptomatic cats

Activation of pancreatic zymogens

Possible lysosomal activation of pancreatic zymogens. Activation of both human trypsinogens by cathepsin B and spontaneous acid. Activation of human trypsinogen 1

The roles of serine protease inhibitor Kazal type 1 (SPINK1) in pancreatic diseases

Endogenous cathepsin activation of trypsinogen in extracts of dog pancreas

Trypsinogen activation in rat pancreatic acinar cells hyperstimulated by caerulein

Early trypsinogen activation in acute pancreatitis

Pathogenic mechanisms of acute pancreatitis

Deletion of IκBα activates RelA to reduce acute pancreatitis in mice through up-regulation of Spi2A

Bile acids induce pancreatic acinar cell injury and pancreatitis by activating calcineurin

Activation of nuclear factor-κB in acinar cells increases the severity of pancreatitis in mice

New insights into the pathogenesis of pancreatitis

Models of acute and chronic pancreatitis

Inflammatory mediators in acute pancreatitis

Analysis in the isolated perfused cat pancreas of factors implicated in the pathogenesis of pancreatitis

The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury

Interleukin-8 and neutrophil activation in acute pancreatitis

A crucial role of nitric oxide in acute lung injury secondary to the acute necrotizing pancreatitis

Kallikrein-kinin system in acute pancreatitis: potential of B 2 -bradykinin antagonists and kallikrein inhibitors

The clinical course of acute pancreatitis and the inflammatory mediators that drive it

Pathophysiology of acute pancreatitis: potential application from experimental models and human medicine to dogs

Interaction of complement and leukocytes in severe acute pancreatitis: potential for therapeutic intervention

Bile-induced acute pancreatitis in cats: roles of bile, bacteria, and pancreatic duct pressure

Does high pancreatic duct pressure compromise the duct mucosal barrier function to pancreatic exocrine proteins?

Cerulein-induced chronic pancreatitis does not require intra-acinar activation of trypsinogen in mice

Effects of oxidative alcohol metabolism on the mitochondrial permeability transition pore and necrosis in a mouse model of alcoholic pancreatitis

Antioxidants and chronic pancreatitis: theory of oxidative stress and trials of antioxidant therapy

Pathology of acute and chronic pancreatitis

Pancreatic interstitial pH in human and feline chronic pancreatitis

Animal models for investigating chronic pancreatitis

Damage to duct epithelium is necessary to develop progressing lesions of chronic pancreatitis in the cat

Pancreatitis in inflammatory bowel diseases

Clinical differentiation of acute necrotizing from chronic nonsuppurative pancreatitis in cats: 63 cases

Incidence and prognostic value of low plasma ionized calcium concentration in cats with acute pancreatitis: 46 cases (1996-1998)

Necrosis and inflammation

Feline exocrine pancreatic disorders

A retrospective study of 157 hospitalized cats with pancreatitis in a tertiary care center: clinical, imaging and laboratory findings, potential prognostic markers and outcome

Textbook of Veterinary Diagnostic Radiology

Ultrasonographic findings in cats with clinical, gross pathologic, and histologic evidence of acute pancreatic necrosis: 20 cases

Feasibility of endoscopic retrograde cholangiopancreatography in healthy cats

Can clinical signs, clinicopathological findings and abdominal ultrasonography predict the site of histopathological abnormalities of the alimentary tract in cats?

Imaging findings in pancreatic neoplasia and nodular hyperplasia in 19 cats

Small Animal Diagnostic Ultrasound

Sonographic evaluation of the normal and abnormal pancreas

Ultrasonography of the normal feline pancreas and associated anatomic landmarks: a prospective study of 20 cats

Agreement of serum feline pancreas-specific lipase and colorimetric lipase assays with pancreatic ultrasonographic findings in cats with suspicion of pancreatitis: 161 cases

Safety of ultrasound-guided fine-needle aspiration of the feline pancreas: a case-control study

Cytology of the pancreas

Cytologic findings and diagnostic yield in 92 dogs undergoing fine-needle aspiration of the pancreas

Contrast-enhanced power and color doppler ultrasonography of the pancreas in healthy and diseased cats

Contrast-enhanced ultrasonography of the pancreas in healthy cats

Evaluation of the feline pancreas using computed tomography and radiolabeled leukocytes

Feline pancreatic ducts are consistently identified on CT and more likely to be dilated in the body of pancreas in cats with elevated feline pancreatic lipase immunoreactivity

Triple phase computed tomography of the pancreas in healthy cats

Computed tomographic angiography of the pancreas in cats with chronic diabetes mellitus compared to normal cats

Computed tomography and MRI of the hepatobiliary system and pancreas

Relationship of pancreatic duct dilation to age and clinical findings in cats

Hepatic and pancreaticobiliary MRI and MR cholangiopancreatography with and without secretin stimulation in normal cats

Magnetic resonance (MR) imaging and MR cholangiopancreatography findings in cats with cholangitis and pancreatitis

Diagnosis of pancreatitis in dogs and cats

Acute kidney injury following acute pancreatitis: a review

Association between serum triglyceride and canine pancreatic lipase immunoreactivity concentrations in miniature schnauzers

Serum triglyceride concentrations in miniature schnauzers with and without a history of probable pancreatitis

A 5-year retrospective cohort study: epidemiology, etiology, severity, and outcomes of acute pancreatitis

Hypertriglyceridemic pancreatitis: presentation and management

Pancreatic secretory enzymes

Methods for lipase detection and assay: a critical review

The 1,2-o-dilauryl-racglycero-3-glutaric acid-(6'-methylresorufin) ester (DGGR) lipase assay in cats and dogs is not specific for pancreatic lipase

Serum trypsin-like immunoreactivity, amylase and lipase in the diagnosis of feline acute pancreatitis

Diagnosis of feline pancreatitis with SNAP fPL and Spec fPL

Evaluation of sonographic parameters as prognostic risk factors in cats with pancreatitis-a retrospective study in 42 cats

Evaluation of feline specific lipase (Spec fPL) for the diagnosis of feline pancreatitis

Evaluation of serum feline pancreatic lipase immunoreactivity and helical computed tomography versus conventional testing for the diagnosis of feline pancreatitis

Retrospective study of the diagnostic utility of Spec fPLin the assessment of 274 sick cats

Elevated canine pancreatic lipase immunoreactivity concentration in dogs with inflammatory bowel disease is associated with a negative outcome

Serial serum feline pancreatic lipase immunoreactivity concentrations and prognostic variables in 33 cats with pancreatitis

Measurement of canine and feline pancreatic lipase immunoreactivityanalytical comparison of new commercial assays with established assays

Comparative repeatability of pancreatic lipase assays in the commercial and in-house laboratory environments

Fundamentals of Veterinary Clinical Pathology

Evaluation of serum feline trypsin-like immunoreactivity for the diagnosis of pancreatitis in cats

Serum and urine concentrations of trypsinogen-activation peptide as markers for acute pancreatitis in cats

Oral cavity, gastrointestinal tract, and associated structures

Pancreatic cytology. Small Animal Cytologic Diagnosis

Cytopathology of the pancreatobiliary tract-the agony, and sometimes, the ease of it

Cell tube block: a new technique to produce cell blocks from fluid cytology samples

Prospective evaluation of laparoscopic pancreatic biopsies in 11 healthy cats

Pancreatic biopsy in normal cats

Comparison of serum Spec fPL (TM) and 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(6 0 -methylresorufin) ester assay in 60 cats using standardized assessment of pancreatic histology

ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs

Pancreatitis in cats: is it acute, is it chronic, is it significant?

s Pathology of Domestic Animals

Diagnostic evaluation of the pancreas

Clinical and pathologic changes in experimentally induced acute pancreatitis in cats

Acute pancreatitis

Chronic pancreatitis, pseudotumors and other tumor-like lesions

Pancreatitis and triaditis in cats: causes and treatment

Pharmacologic management and prevention of acute pancreatitis

Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes in-hospital mortality

Early aggressive hydration hastens clinical improvement in mild acute pancreatitis

In vivo interaction between trypsin and some plasma proteins in relation to tolerance to intravenous infusion of trypsin in dogs

Low-dose dopamine protects against hemorrhagic-pancreatitis in cats

Sources of pancreatic pathogens in acute pancreatitis in cats

Antimicrobial treatment of pancreatic infection in cats

Acute primary toxoplasmic pancreatitis in a cat

Fluid resuscitation in acute pancreatitis

Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs

Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (CereniaTM) for the prevention of emesis and motion sickness in cats

Effect of maropitant, a neurokinin-1 receptor antagonist, on the minimum alveolar concentration of sevoflurane during stimulation of the ovarian ligament in cats

The anti-inflammatory action of maropitant in a mouse model of acute pancreatitis

Ultrasonographic assessment of the effect of metoclopramide, erythromycin, and exenatide on solid-phase gastric emptying in healthy cats

Effect of bethanechol and metoclopramide on upper gastrointestinal motility in the kitten

Effects of bethanechol, metoclopramide, and domperidone on antral contractions in cats and dogs

Acute vomiting in cats

Pharmacokinetics and suggested oral dosing regimen of cisapride: a study in healthy cats

Diagnosis and treatment of gastric motility disorders

Managing pain in feline patients

Refinement and initial validation of a multidimensional composite scale for use in assessing acute postoperative pain in cats

Validation of the English version of the UNESP-Botucatu multidimensional composite pain scale for assessing postoperative pain in cats

Pain treatment in patients with acute pancreatitis: a randomized controlled trial

The pain of chronic pancreatitis: a persistent clinical challenge

Pharmacokinetics of tramadol, and its metabolite O-desmethyl-tramadol, in cats

Evaluation of tramadol for treatment of osteoarthritis in geriatric cats

The pharmacokinetics of gabapentin in cats

Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impairment and quality of life in osteoarthritic geriatric cats

Mirtazapine toxicity in cats: retrospective study of 84 cases

Mirtazapine as an appetite stimulant and antiemetic in cats with chronic kidney disease: a masked placebocontrolled crossover clinical trial

A double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss

Evaluation of the safety of daily administration of capromorelin in cats

Nutrition support in acute pancreatitis

The gut's role in metabolism, mucosal barrier function, and gut immunology

What is the best way to feed patients with pancreatitis?

A randomized controlled trial of enteral versus parenteral feeding in patients with predicted severe acute pancreatitis shows a significant reduction in mortality and in infected pancreatic complications with total enteral nutrition

Early enteral nutrition in severe acute pancreatitis: a prospective randomized controlled trial comparing nasojejunal and nasogastric routes

International consensus guidelines for nutrition therapy in pancreatitis

Acute pancreatitis

Nasogastric tube feeding in cats with suspected acute pancreatitis: 55 cases

A randomised clinical trial to assess the effect of total enteral and total parenteral nutritional support on metabolic, inflammatory and oxidative markers in patients with predicted severe acute pancreatitis (APACHEE II ≥6)

Enteral nutrition and acute pancreatitis: a review

Effect of early intrajejunal nutrition on pancreatic pathological features and gut barrier function in dogs with acute pancreatitis

Effect of parenteral and early intrajejunal nutrition on pancreatic digestive enzyme synthesis, storage and discharge in dog models of acute pancreatitis

Parenteral versus early intrajejunal nutrition: effect on pancreatitic natural course, enterohormones release and its efficacy on dogs with acute pancreatitis

A pilot study to assess tolerability of early enteral nutrition via esophagostomy tube feeding in dogs with severe acute pancreatitis

Nutritional management of acute pancreatitis in dogs and cats

Critical care nutrition for feline patients

Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain

Introduction to Feeding in Normal Cats

Comparison of fasting, nasogastric suction and cimetidine in the treatment of acute pancreatitis

Prospective, randomized trial of nasogastric suction in patients with acute pancreatitis

Retrospective evaluation of partial parenteral nutrition in dogs and cats

Pulmonary thromboembolism in cats

Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis

A multicentre controlled clinical trial of high-volume fresh frozen plasma therapy in prognostically severe acute pancreatitis

Evaluation of fresh frozen plasma administration in dogs with pancreatitis: 77 cases (1995-2005)

American college of gastroenterology guideline: management of acute pancreatitis

Review of feline pancreatitis part two: clinical signs, diagnosis and treatment

Evaluation of fluorescence in situ hybridization for the detection of bacteria in feline inflammatory liver disease

Pharmacological approach to acute pancreatitis

Stability of canine pancreatic lipase immunoreactivity concentration in serum samples and effects of long-term administration of prednisone to dogs on serum canine pancreatic lipase immunoreactivity concentrations

Effects of dexamethasone on pancreatic tissue and on serum amylase and lipase activities in dogs

Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins

Critical illness-related corticosteroid insufficiency in patients with severe acute biliary pancreatitis: a prospective cohort study

Comparison of initial treatment with and without corticosteroids for suspected acute pancreatitis in dogs

Corticosteroid therapy for severe acute pancreatitis: a meta-analysis of randomized, controlled trials

Radiographic, epidemiologic, and clinical aspects of simultaneous pleural and peritoneal effusions in dogs and cats: 48 cases (1982-1991)

Retrospective study: surgical intervention in the management of severe acute pancreatitis in cats: 8 cases

Hyperbaric oxygen therapy for severe acute pancreatitis

Hyperbaric oxygen therapy reduces severity and improves survival in severe acute pancreatitis

Hyperbaric oxygen therapy effects on tissue lesions in acute pancreatitis. Experimental study in rats

Hyperbaric oxygen ameliorated acute pancreatitis in rats via the mitochondrial pathway

Executive summary: WSES guidelines for the management of severe acute pancreatitis

Serum ionised calcium as a prognostic risk factor in the clinical course of pancreatitis in cats

The epidemiology of pancreatitis and pancreatic cancer

Analgesia for anesthetized patients

Adjunctive analgesic therapy in veterinary medicine

Experimental acute pancreatitis new insights into the pathophysiology

Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes

Antinerve growth factor monoclonal antibodies for the control of pain in dogs and cats

Cyclosporin and chronic pancreatitis: a supermodel?

Drug-induced acute pancreatitis

Toxoplasma gondii-associated cholecystitis in a cat receiving immunosuppressive treatment

Antemortem diagnosis and treatment of toxoplasmosis in two cats on cyclosporin therapy

Management of hypertension controls postoperative neurologic disorders after renal transplantation in cats

A case of fatal systemic toxoplasmosis in a cat being treated with cyclosporin a for feline atopy

Supporting Information section at the end of this article. How to cite this article

ACVIM consensus statement on pancreatitis in cats